Evidence map›Paper›PMID 11792833›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.

Deborah Thompson, Csilla I Szabo, Jon Mangion, Rogier A Oldenburg, Fabrice Odefrey, Sheila Seal, Rita Barfoot, Karin Kroeze-Jansema, Dawn Teare, Nazneen Rahman and 39 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 92 citations in OpenAlex.

  1. The Role of Emerin in Cancer Progression and Metastasis.International journal of molecular sciences · 2021
    Review
  2. Molecular Trajectory ofFrontiers in oncology · 2020
    Review
  3. Oncotarget · 2017
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. BAP1 and breast cancer risk.Familial cancer · 2005
    Article
  18. The genetic epidemiology of breast cancer genes.Journal of mammary gland biology and neoplasia · 2004
    Review
  19. Article
  20. Molecular classification of familial non-BRCA1/BRCA2 breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

49 authors at 8 institutions in 4 countries.

Deborah ThompsonCRC Genetic Epidemiology Unit, Strangeways Research Laboratories, University of Cambridge, Cambridge CB1 4RN, United Kingdom.
Csilla I Szabo
Jon Mangion
Rogier A Oldenburg
Fabrice Odefrey
Sheila Seal
Rita Barfoot
Karin Kroeze-Jansema
Dawn Teare
Nazneen Rahman
Hélène Renard
Graham Mann
John L Hopper
Saundra S Buys
Irene L Andrulis
Ruby Senie
Mary B Daly
Dee West
Elaine A Ostrander
Ken Offit
Tamar Peretz
Ana Osorio
J Benitez
Katherine L Nathanson
Olga M Sinilnikova
Edith Olàh
Yves-Jean Bignon
Pablo Ruiz
Michael D Badzioch
Hans F A Vasen
Andrew P Futreal
Catherine M Phelan
Steven A Narod
Henry T Lynch
Bruce A J Ponder
Ros A Eeles
Hanne Meijers-Heijboer
Dominique Stoppa-Lyonnet
Fergus J Couch
Diana M Eccles
D Gareth Evans
Jenny Chang-Claude
Gilbert Lenoir
Barbara L Weber
Peter Devilee
Douglas F Easton
David E Goldgar
Michael R Stratton
KConFab Consortium
Imperial College London · GBInstituto de Salud Carlos III · ESCentre Jean Perrin · FRInstitut Curie · FRMayo Clinic · USNorthern California Research · USPrincess Anne Hospital · GBRoyal Marsden NHS Foundation Trust · GB

Funding

Northern California Cooperative Family Registry for Breast CancerU01CA069417 · NCI · NORTHERN CALIFORNIA CANCER CENTER · PI JOHN, ESTHER M. · 1995 to 2010
$22.4M
METROPOLITAN NEW YORK REGISTRY OF BREAST CANCER FAMILIESU01CA069398 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI TERRY, MARY BETH · 1995 to 2010
$10.5M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL BREAST CANCERU01CA069467 · NCI · CANCER CARE ONTARIO · PI ANDRULIS, IRENE L. · 1995 to 2010
$10.4M
Philadelphia Breast Cancer Family RegistryU01CA069631 · NCI · FOX CHASE CANCER CENTER · PI DALY, MARY BERYL · 1995 to 2010
$7.4M
THE AUSTRALIAN BREAST CANCER FAMILY REGISTRYU01CA069638 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 1995 to 2010
$6.6M
Utah Breast Cancer Family RegistryU01CA069446 · NCI · UNIVERSITY OF UTAH · PI BUYS, SAUNDRA S · 1995 to 2010
$4.6M
NCI NIH HHS CA69398NCI NIH HHS CA69417NCI NIH HHS CA69446NCI NIH HHS CA69467NCI NIH HHS CA69631NCI NIH HHS CA69638NCI NIH HHS U01 CA069398NCI NIH HHS U01 CA069417NCI NIH HHS U01 CA069446NCI NIH HHS U01 CA069467NCI NIH HHS U01 CA069631NCI NIH HHS U01 CA069638
6 · The paper itself

Abstract

The known susceptibility genes for breast cancer, including BRCA1 and BRCA2, only account for a minority of the familial aggregation of the disease. A recent study of 77 multiple case breast cancer families from Scandinavia found evidence of linkage between the disease and polymorphic markers on chromosome 13q21. We have evaluated the contribution of this candidate "BRCA3" locus to breast cancer susceptibility in 128 high-risk breast cancer families of Western European ancestry with no identified BRCA1 or BRCA2 mutations. No evidence of linkage was found. The estimated proportion (alpha) of families linked to a susceptibility locus at D13S1308, the location estimated by Kainu et al. [(2000) Proc. Natl. Acad. Sci. USA 97, 9603-9608], was 0 (upper 95% confidence limit 0.13). Adjustment for possible bias due to selection of families on the basis of linkage evidence at BRCA2 did not materially alter this result (alpha = 0, upper 95% confidence limit 0.18). The proportion of linked families reported by Kainu et al. (0.65) is excluded with a high degree of confidence in our dataset [heterogeneity logarithm of odds (HLOD) at alpha = 0.65 was -11.0]. We conclude that, if a susceptibility gene does exist at this locus, it can only account for a small proportion of non-BRCA1/2 families with multiple cases of early-onset breast cancer.

Indexed as

Genes, Tumor SuppressorGenetic LinkageAustraliaBreast NeoplasmsChromosomes, Human, Pair 13EuropeFemaleHumansLod ScoreNorth America

Identifiers

PMID11792833
PMCPMC117390
OpenAlexW2045939414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.